* Apyx Medical Corp reported a quarterly adjusted loss of 22 cents per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of -10 cents. The mean expectation of five analysts for the quarter was for a loss of 21 cents per share. Wall Street expected results to range from -27 cents to -16 cents per share.
* Revenue fell 15.6% to $10.24 million from a year ago; analysts expected $9.53 million.
* Apyx Medical Corp's reported EPS for the quarter was a loss of 22 cents.
* The company reported a quarterly loss of $7.58 million.
* Apyx Medical Corp shares had fallen by 0.7% this quarter and lost 48.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 59.8% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Apyx Medical Corp is $2.25 This summary was machine generated from LSEG data May 9 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.21 -0.22 Missed
Dec. 31 2023 -0.18 -0.28 Missed
Sep. 30 2023 -0.11 -0.13 Missed
Jun. 30 2023 -0.07 -0.11 Missed
Comments